Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells (Q84479975)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21719142 AND SRC:MED&resulttype=core&format=json

6 February 2020

title

Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21719142 AND SRC:MED&resulttype=core&format=json

non-small-cell lung carcinoma

6 February 2020

main subject

1 reference

Hiroyuki Tao

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21719142 AND SRC:MED&resulttype=core&format=json

6 February 2020

Yusuke Mimura

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21719142 AND SRC:MED&resulttype=core&format=json

6 February 2020

Keisuke Aoe

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21719142 AND SRC:MED&resulttype=core&format=json

6 February 2020

Seiki Kobayashi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21719142 AND SRC:MED&resulttype=core&format=json

6 February 2020

Hiromasa Yamamoto

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21719142 AND SRC:MED&resulttype=core&format=json

6 February 2020

Eisuke Matsuda

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21719142 AND SRC:MED&resulttype=core&format=json

6 February 2020

Kazunori Okabe

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21719142 AND SRC:MED&resulttype=core&format=json

6 February 2020

Tsuneo Matsumoto

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21719142 AND SRC:MED&resulttype=core&format=json

6 February 2020

Kazurou Sugi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21719142 AND SRC:MED&resulttype=core&format=json

6 February 2020

Hiroshi Ueoka

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21719142 AND SRC:MED&resulttype=core&format=json

6 February 2020

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21719142

6 December 2024

publication date

29 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21719142 AND SRC:MED&resulttype=core&format=json

full work available at URL

6 February 2020

https://api.elsevier.com/content/article/PII:S016950021100331X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.06.002

https://api.elsevier.com/content/article/PII:S016950021100331X?httpAccept=text/plain

6 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.06.002

6 December 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21719142 AND SRC:MED&resulttype=core&format=json

6 February 2020

volume

75

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21719142 AND SRC:MED&resulttype=core&format=json

6 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21719142 AND SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

95-101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21719142 AND SRC:MED&resulttype=core&format=json

https://opencitations.net/index/coci/api/v1/citations/10.3322/CAAC.20006

6 February 2020

cites work

Cancer statistics, 2009

1 reference

28 May 2022

Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline

2

1 reference

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.06.002

Adjuvant chemotherapy for early-stage non-small cell lung cancer: the past, the present and the future

6 December 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.06.002

Polarized immune responses differentially regulate cancer development

6 December 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.06.002

Immunity, Inflammation, and Cancer

6 December 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.06.002

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

6 December 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.06.002

Prevalence of FOXP3 regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions

6 December 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.06.002

FOXP3 regulatory T cells affect the development and progression of hepatocarcinogenesis.

6 December 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.06.002

Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse

6 December 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.06.002

Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome.

6 December 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.06.002

Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8 /regulatory T-cell ratio: which variable determines survival of cervical cancer patients?

6 December 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.06.002

Localisation pattern of Foxp3 regulatory T cells is associated with clinical behaviour in gastric cancer

6 December 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.06.002

Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

6 December 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.06.002

Tumor infiltrating Foxp3 regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients

6 December 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.06.002

Tumor-infiltrating Foxp3 regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer

6 December 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.06.002

Foxp3 programs the development and function of CD4 CD25 regulatory T cells

6 December 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.06.002

FOXP3 regulatory T cells in the human immune system

6 December 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.06.002

Control of regulatory T cell development by the transcription factor Foxp3

6 December 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.06.002

Foxp3 Expression in Pancreatic Carcinoma Cells as a Novel Mechanism of Immune Evasion in Cancer

6 December 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.06.002

The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells.

6 December 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.06.002

FOXP3 expression and overall survival in breast cancer.

6 December 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.06.002

Presence of Foxp3 expression in tumor cells predicts better survival in HER2-overexpressing breast cancer patients treated with neoadjuvant chemotherapy

6 December 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.06.002

Somatic single hits inactivate the X-linked tumor suppressor FOXP3 in the prostate

6 December 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.06.002

Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer

6 December 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.06.002

Influence of Smoking Cessation on Airway T Lymphocyte Subsets in COPD

6 December 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.06.002

Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4 CD25 regulatory T-lymphocyte response to tobacco smoking

6 December 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.06.002

A central role for Foxp3 regulatory T cells in K-Ras-driven lung tumorigenesis

6 December 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.06.002

6 December 2024

Human FOXP3 and cancer

29

1 reference

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.06.002

Foxp3 expression in p53-dependent DNA damage responses

6 December 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.06.002

Cutting edge: Foxp3 CD4 CD25 regulatory T cells induced by IL-2 and TGF-beta are resistant to Th17 conversion by IL-6.

6 December 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.06.002

Serum concentrations of cytokines and lung cancer survival in African Americans and Caucasians

6 December 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.06.002

FOXP3 and its partners: structural and biochemical insights into the regulation of FOXP3 activity

6 December 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.06.002

6 December 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21719142 AND SRC:MED&resulttype=core&format=json

6 February 2020

1 reference